PMV Pharmaceuticals (PMVP) Stock Chart & Stock Price History → The Department of Defense Has a New Drone Contractor (From The Tomorrow Investor) (Ad) Free PMVP Stock Alerts $2.17 +0.13 (+6.37%) (As of 09:33 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media PMV Pharmaceuticals Stock Price Performance5 Day Performance+0.46%1 Month Performance+21.23%3 Month Performance+42.76%6 Month Performance+6.90%Year-To-Date Performance-30.00%1 Year Performance-61.93% Receive PMVP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PMV Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Paradigm PressForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. PMVP Stock Chart for Monday, May, 13, 2024 PMVP Chart by TradingView PMV Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/10/2024$2.10$2.04-2.86%$2.16$1.98311,504 shs$104.94 million05/09/2024$2.16$2.10-2.78%$2.14$2.05261,934 shs$108.02 million05/08/2024$2.18$2.16-0.92%$2.25$2.11735,324 shs$111.11 million05/07/2024$2.10$2.18+3.81%$2.21$2.07738,648 shs$112.14 million05/06/2024$1.99$2.10+5.53%$2.19$1.961.44 million shs$108.03 million05/03/2024$1.87$1.99+6.42%$2.01$1.891.27 million shs$102.37 million Get the Latest News and Ratings for PMVP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PMV Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/02/2024$1.86$1.87+0.54%$1.92$1.83292,245 shs$96.19 million05/01/2024$1.80$1.86+3.33%$1.88$1.81426,501 shs$95.68 million04/30/2024$1.77$1.80+1.69%$1.83$1.73217,557 shs$92.59 million04/29/2024$1.75$1.77+1.14%$1.84$1.75263,319 shs$91.05 million04/26/2024$1.71$1.75+2.34%$1.77$1.69336,037 shs$90.02 million04/25/2024$1.69$1.71+1.18%$1.72$1.66347,999 shs$87.96 million04/24/2024$1.81$1.69-6.37%$1.80$1.69201,872 shs$86.93 million04/23/2024$1.73$1.81+4.34%$1.85$1.71371,068 shs$92.85 million04/22/2024$1.61$1.73+7.45%$1.76$1.60538,199 shs$89.00 million04/19/2024$1.62$1.61-0.62%$1.66$1.58479,632 shs$82.82 million04/18/2024$1.61$1.62+0.62%$1.66$1.58464,028 shs$83.33 million04/17/2024$1.60$1.61+0.63%$1.66$1.60276,990 shs$82.82 million04/16/2024$1.64$1.60-2.14%$1.65$1.57330,778 shs$82.30 million04/15/2024$1.79$1.64-8.66%$1.81$1.61585,661 shs$84.10 million04/12/2024$1.58$1.79+13.29%$1.82$1.651.70 million shs$92.08 million04/11/2024$1.51$1.58+4.64%$1.60$1.52226,576 shs$81.28 million04/10/2024$1.58$1.51-4.43%$1.58$1.49410,092 shs$77.67 million04/09/2024$1.56$1.58+1.28%$1.61$1.52355,988 shs$81.28 million04/08/2024$1.60$1.56-2.50%$1.62$1.51519,048 shs$80.25 million04/05/2024$1.60$1.60$1.62$1.56297,178 shs$82.30 million04/04/2024$1.70$1.60-5.88%$1.73$1.57649,955 shs$82.30 million04/03/2024$1.79$1.70-5.03%$1.81$1.68577,541 shs$87.45 million04/02/2024$1.78$1.79+0.56%$1.84$1.74285,942 shs$92.08 million04/01/2024$1.70$1.78+4.71%$1.79$1.63459,990 shs$91.56 million03/29/2024$1.70$1.70$1.71$1.64643,441 shs$87.45 million03/28/2024$1.65$1.70+3.03%$1.71$1.64643,361 shs$87.45 million03/27/2024$1.66$1.65-0.60%$1.72$1.58888,921 shs$84.88 million03/26/2024$1.70$1.66-2.35%$1.74$1.65502,747 shs$85.39 million03/25/2024$1.69$1.70+0.59%$1.76$1.70676,951 shs$87.45 million03/22/2024$1.72$1.69-1.74%$1.71$1.64553,728 shs$86.93 million03/21/2024$1.67$1.72+2.99%$1.79$1.70317,918 shs$88.48 million03/20/2024$1.69$1.67-1.18%$1.71$1.60569,876 shs$85.91 million03/19/2024$1.67$1.69+1.20%$1.79$1.67768,086 shs$86.93 million03/18/2024$1.76$1.67-5.11%$1.81$1.67319,860 shs$85.91 millionThe Department of Defense Has a New Drone Contractor (Ad)The Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.Click here to see how to invest03/15/2024$1.65$1.76+6.67%$1.77$1.65963,932 shs$90.53 million03/14/2024$1.60$1.65+3.12%$1.71$1.62579,406 shs$84.88 million03/13/2024$1.65$1.60-3.03%$1.73$1.60562,711 shs$82.31 million03/12/2024$1.63$1.65+1.23%$1.67$1.502.00 million shs$84.88 million03/11/2024$1.70$1.63-4.12%$1.72$1.62982,048 shs$83.85 million03/08/2024$1.86$1.70-8.60%$1.88$1.631.16 million shs$87.45 million03/07/2024$1.93$1.86-3.63%$1.95$1.84917,321 shs$95.68 million03/06/2024$1.88$1.93+2.66%$1.94$1.84274,201 shs$99.28 million03/05/2024$1.87$1.88+0.53%$1.91$1.81425,225 shs$96.71 million03/04/2024$1.88$1.87-0.27%$1.90$1.81575,004 shs$95.67 million03/01/2024$1.85$1.88+1.35%$2.11$1.80839,381 shs$95.93 million02/29/2024$1.81$1.85+2.21%$1.91$1.77356,436 shs$94.64 million02/28/2024$1.88$1.81-3.72%$1.91$1.79380,216 shs$92.60 million02/27/2024$1.80$1.88+4.44%$1.93$1.78388,319 shs$96.18 million02/26/2024$1.67$1.80+7.78%$1.83$1.70586,506 shs$92.09 million02/23/2024$1.73$1.67-3.47%$1.76$1.65383,514 shs$85.44 million02/22/2024$1.69$1.73+2.37%$1.77$1.65345,203 shs$88.51 million02/21/2024$1.60$1.69+5.62%$1.70$1.59397,789 shs$86.46 million02/20/2024$1.54$1.60+3.90%$1.61$1.52324,519 shs$81.86 million02/19/2024$1.54$1.54$1.56$1.50328,900 shs$78.78 million02/16/2024$1.53$1.54+0.65%$1.56$1.50328,936 shs$78.79 million02/15/2024$1.51$1.53+1.32%$1.60$1.52390,069 shs$78.27 million02/14/2024$1.52$1.51-0.66%$1.55$1.461.73 million shs$77.25 million02/13/2024$1.67$1.52-8.98%$1.62$1.50664,313 shs$77.76 million02/12/2024$1.68$1.67-0.60%$1.72$1.571.03 million shs$85.44 million Related Companies: Relmada Therapeutics Stock Price Chart Citius Pharmaceuticals Stock Price Chart Rezolute Stock Price Chart Allakos Stock Price Chart Cyteir Therapeutics Stock Price Chart OptiNose Stock Price Chart Cellectar Biosciences Stock Price Chart Cue Biopharma Stock Price Chart Assertio Stock Price Chart Genelux Stock Price Chart Receive PMVP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for PMV Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PMVP) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorTrump is sounding the alarmPreserve GoldBill Clinton Backing Biden Replacement???The Freeport SocietyThis 1 Biotech Stock has been shocking the marketsHuge AlertsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PMV Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.